FDA OKs broader use of ergo imaging system

01/31/2013 | MedGadget.com

Digirad has received FDA clearance for expanded use of its ergo imaging system. The broader clearance covers lymphatic scintigraphy and parathyroid scintigraphy for evaluation of lesions in the breast and elsewhere in the body. The device was first cleared three years ago by the FDA.

View Full Article in:

MedGadget.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Counsel I – Clinical Contracts
Gilead Sciences
Foster City, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Vice President, Idaho Regional Director
PacificSource
Boise, ID